BACKGROUND: High chronic exposure to inorganic arsenic may contribute to the development of hypertension. Limited information is available, however, on the association of low to moderate exposure to inorganic arsenic with blood pressure levels and hypertension. We investigated the association of exposure to inorganic arsenic (as measured in urine) with systolic and diastolic blood pressure levels and the prevalence of hypertension in US adults. METHODS: We studied 4167 adults 20 years of age or older who participated in the National Health and Nutrition Examination Survey (NHANES) from 2003 through 2008 and for whom total arsenic, dimethylarsinate (DMA), and arsenobetaine had been assessed in urine. RESULTS: The median (interquartile range) urine concentrations were 8.3 μg/L (4.2-17.1) for total arsenic, 3.6 μg/L (2.0-6.0) for DMA, and 1.4 μg/L (0.3-6.3) for arsenobetaine. The weighted prevalence of hypertension in the study population was 36%. After multivariable adjustment, a 2-fold increase in total arsenic was associated with a hypertension odds ratio of 0.98 (95% confidence interval = 0.86-1.11). A doubling of total arsenic minus arsenobetaine was associated with a hypertension OR of 1.03 (0.94-1.14) and a doubling of DMA concentrations was associated with a hypertension OR of 1.11 (0.99-1.24). Total arsenic, total arsenic minus arsenobetaine, or DMA levels were not associated with systolic or diastolic blood pressure. CONCLUSIONS: At the low to moderate levels, typical of the US population, total arsenic, total arsenic minus arsenobetaine, and DMA concentrations in urine were not associated with the prevalence of hypertension or with systolic or diastolic blood pressure levels. A weak association of DMA with hypertension could not be ruled out.
BACKGROUND: High chronic exposure to inorganic arsenic may contribute to the development of hypertension. Limited information is available, however, on the association of low to moderate exposure to inorganic arsenic with blood pressure levels and hypertension. We investigated the association of exposure to inorganic arsenic (as measured in urine) with systolic and diastolic blood pressure levels and the prevalence of hypertension in US adults. METHODS: We studied 4167 adults 20 years of age or older who participated in the National Health and Nutrition Examination Survey (NHANES) from 2003 through 2008 and for whom total arsenic, dimethylarsinate (DMA), and arsenobetaine had been assessed in urine. RESULTS: The median (interquartile range) urine concentrations were 8.3 μg/L (4.2-17.1) for total arsenic, 3.6 μg/L (2.0-6.0) for DMA, and 1.4 μg/L (0.3-6.3) for arsenobetaine. The weighted prevalence of hypertension in the study population was 36%. After multivariable adjustment, a 2-fold increase in total arsenic was associated with a hypertension odds ratio of 0.98 (95% confidence interval = 0.86-1.11). A doubling of total arsenic minus arsenobetaine was associated with a hypertension OR of 1.03 (0.94-1.14) and a doubling of DMA concentrations was associated with a hypertension OR of 1.11 (0.99-1.24). Total arsenic, total arsenic minus arsenobetaine, or DMA levels were not associated with systolic or diastolic blood pressure. CONCLUSIONS: At the low to moderate levels, typical of the US population, total arsenic, total arsenic minus arsenobetaine, and DMA concentrations in urine were not associated with the prevalence of hypertension or with systolic or diastolic blood pressure levels. A weak association of DMA with hypertension could not be ruled out.
Authors: J Pi; Y Kumagai; G Sun; H Yamauchi; T Yoshida; H Iso; A Endo; L Yu; K Yuki; T Miyauchi; N Shimojo Journal: Free Radic Biol Med Date: 2000-04-01 Impact factor: 7.376
Authors: M R Karagas; C X Le; S Morris; J Blum; X Lu; V Spate; M Carey; V Stannard; B Klaue; T D Tosteson Journal: Int J Occup Med Environ Health Date: 2001 Impact factor: 1.843
Authors: S K Feseke; J St-Laurent; E Anassour-Sidi; P Ayotte; M Bouchard; P Levallois Journal: Health Promot Chronic Dis Prev Can Date: 2015-06 Impact factor: 3.240
Authors: Ami R Zota; Belinda L Needham; Elizabeth H Blackburn; Jue Lin; Sung Kyun Park; David H Rehkopf; Elissa S Epel Journal: Am J Epidemiol Date: 2014-12-10 Impact factor: 4.897
Authors: Emily M Hall; Johanna Acevedo; Francisca González López; Sandra Cortés; Catterina Ferreccio; Allan H Smith; Craig M Steinmaus Journal: Environ Res Date: 2016-12-02 Impact factor: 6.498
Authors: Gernot Pichler; Maria Grau-Perez; Maria Tellez-Plaza; Jason Umans; Lyle Best; Shelley Cole; Walter Goessler; Kevin Francesconi; Jonathan Newman; Josep Redon; Richard Devereux; Ana Navas-Acien Journal: Circ Cardiovasc Imaging Date: 2019-05 Impact factor: 7.792
Authors: Miranda J Spratlen; Maria Grau-Perez; Lyle G Best; Joseph Yracheta; Mariana Lazo; Dhananjay Vaidya; Poojitha Balakrishnan; Mary V Gamble; Kevin A Francesconi; Walter Goessler; Shelley A Cole; Jason G Umans; Barbara V Howard; Ana Navas-Acien Journal: Am J Epidemiol Date: 2018-08-01 Impact factor: 4.897
Authors: Julie Kunrath; Eugen Gurzau; Anca Gurzau; Walter Goessler; Elyssa R Gelmann; Thu-Trang Thach; Kathleen M McCarty; Catherine W Yeckel Journal: J Hypertens Date: 2013-02 Impact factor: 4.844